Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2021 Filed Dec 14, 2021 23:31 UTC |
RAMSAY DAVID ADirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001209191-21-069587 · doc4.xml · derivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-12-14 F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 14, 2022. Read SEC document |
| December 14, 2021 Filed Dec 14, 2021 23:31 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 350,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001209191-21-069586 · doc4.xml · derivative · entry 2 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2031-12-14 F2 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2021, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 14, 2021 Filed Dec 14, 2021 23:31 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 400,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-069586 · doc4.xml · nonDerivative · entry 1 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 783,672 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 14, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 14, 2021 Filed Dec 14, 2021 23:28 UTC |
Lowrance David LCHIEF FINANCIAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001209191-21-069583 · doc4.xml · derivative · entry 2 Lowrance David L · CIK 0001408498 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-12-14 F2 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2021, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 14, 2021 Filed Dec 14, 2021 23:28 UTC |
Lowrance David LCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-069583 · doc4.xml · nonDerivative · entry 1 Lowrance David L · CIK 0001408498 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,793 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 14, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 14, 2021 Filed Dec 14, 2021 23:29 UTC |
McCracken Joseph SDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001209191-21-069585 · doc4.xml · derivative · entry 1 McCracken Joseph S · CIK 0001632454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-12-14 F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 14, 2022. Read SEC document |
| December 14, 2021 Filed Dec 14, 2021 23:28 UTC |
Hawkins Richard JDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001209191-21-069582 · doc4.xml · derivative · entry 3 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-12-14 F2 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 14, 2022. Read SEC document |
| December 14, 2021 Filed Dec 14, 2021 23:27 UTC |
Elam Nevan CDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001209191-21-069581 · doc4.xml · derivative · entry 1 Elam Nevan C · CIK 0001314773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-12-14 F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 14, 2022. Read SEC document |
| December 14, 2021 Filed Dec 14, 2021 23:26 UTC |
Chowdhury Badrul A.CHIEF MEDICAL OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001209191-21-069579 · doc4.xml · derivative · entry 2 Chowdhury Badrul A. · CIK 0001776662 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-12-14 F2 · derivative.exercise_date: The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2021, subject to the reporting person's continued service with the Issuer. Read SEC document |
| December 14, 2021 Filed Dec 14, 2021 23:26 UTC |
Chowdhury Badrul A.CHIEF MEDICAL OFFICER
|
GrantCommon Stock | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-069579 · doc4.xml · nonDerivative · entry 1 Chowdhury Badrul A. · CIK 0001776662 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 14, 2023. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 23:30 UTC |
Sun RickyDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0000899243-21-048398 · doc4.xml · derivative · entry 1 Sun Ricky · CIK 0001790589 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-12-14 F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 14, 2022. Read SEC document |
| December 13, 2021 Filed Dec 14, 2021 23:28 UTC |
Hawkins Richard JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 728 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001209191-21-069582 · doc4.xml · derivative · entry 2 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 728 shares Expires 2021-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 16, 2012. Read SEC document |
| December 13, 2021 Filed Dec 14, 2021 23:28 UTC |
Hawkins Richard JDirector
|
Exercise / conversionCommon Stock | 728 | $0.55 | $400.40 |
DisclosureSEC source: 0001209191-21-069582 · doc4.xml · nonDerivative · entry 1 Hawkins Richard J · CIK 0001307632 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2021 Filed Dec 13, 2021 19:05 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 35,000 | $1.04 | $36,365.00 |
DisclosureSEC source: 0001209191-21-069189 · doc4.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,411,142 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.03 to $1.04. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| December 09, 2021 Filed Dec 9, 2021 15:59 UTC |
Chowdhury Badrul A.CHIEF MEDICAL OFFICER
|
PurchaseCommon Stock | 25,000 | $1.05 | $26,250.00 |
DisclosureSEC source: 0001209191-21-068649 · doc4.xml · nonDerivative · entry 1 Chowdhury Badrul A. · CIK 0001776662 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 19:41 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 6,500 | $1.06 | $6,889.35 |
DisclosureSEC source: 0001209191-21-068494 · doc4.xml · nonDerivative · entry 1 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,672 Read SEC document |
| December 08, 2021 Filed Dec 9, 2021 17:12 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 13,157 | $1.05 | $13,814.85 |
DisclosureSEC source: 0001209191-21-068660 · doc4.xml · nonDerivative · entry 2 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,376,142 Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 17:12 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 11,843 | $1.05 | $12,399.62 |
DisclosureSEC source: 0001209191-21-068660 · doc4.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,362,985 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.04 to $1.05. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 23:00 UTC |
Elam Nevan CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,172 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001209191-21-068571 · doc4.xml · derivative · entry 2 Elam Nevan C · CIK 0001314773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,172 shares Expires 2021-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on March 16, 2012. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 23:00 UTC |
Elam Nevan CDirector
|
Exercise / conversionCommon Stock | 1,172 | $0.55 | $644.60 |
DisclosureSEC source: 0001209191-21-068571 · doc4.xml · nonDerivative · entry 1 Elam Nevan C · CIK 0001314773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,072 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 02, 2021 Filed Dec 2, 2021 17:48 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 21,394 | $1.09 | $23,233.88 |
DisclosureSEC source: 0001209191-21-067437 · doc4.xml · nonDerivative · entry 2 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,351,142 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.08 to $1.09. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| December 02, 2021 Filed Dec 2, 2021 17:28 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 10,000 | $1.10 | $10,954.00 |
DisclosureSEC source: 0001209191-21-067432 · doc4.xml · nonDerivative · entry 1 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,172 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.0925 to $1.10. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| December 01, 2021 Filed Dec 1, 2021 18:15 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 9,000 | $1.09 | $9,765.00 |
DisclosureSEC source: 0001209191-21-067244 · doc4.xml · nonDerivative · entry 2 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,326,142 F2 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.08 to $1.105. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 17:48 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 3,606 | $1.08 | $3,894.48 |
DisclosureSEC source: 0001209191-21-067437 · doc4.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,329,748 Read SEC document |
| November 30, 2021 Filed Dec 1, 2021 18:15 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 16,000 | $1.09 | $17,392.00 |
DisclosureSEC source: 0001209191-21-067244 · doc4.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,317,142 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.08 to $1.10. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| November 22, 2021 Filed Nov 22, 2021 16:43 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 90,000 | $1.08 | $97,020.00 |
DisclosureSEC source: 0001209191-21-066037 · doc4.xml · nonDerivative · entry 3 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,301,142 F3 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.06 to $1.09. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 16:43 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 49,800 | $1.07 | $53,236.20 |
DisclosureSEC source: 0001209191-21-066037 · doc4.xml · nonDerivative · entry 2 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,211,142 F2 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.06 to $1.08. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 16:42 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 2,150 | $1.07 | $2,289.75 |
DisclosureSEC source: 0001209191-21-066036 · doc4.xml · nonDerivative · entry 3 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,172 Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 16:42 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 10,000 | $1.11 | $11,100.00 |
DisclosureSEC source: 0001209191-21-066036 · doc4.xml · nonDerivative · entry 2 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,022 Read SEC document |
| November 18, 2021 Filed Nov 22, 2021 16:43 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 60,200 | $1.08 | $65,136.40 |
DisclosureSEC source: 0001209191-21-066037 · doc4.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,161,342 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.06 to $1.10. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| November 18, 2021 Filed Nov 22, 2021 16:42 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 10,000 | $1.10 | $11,000.00 |
DisclosureSEC source: 0001209191-21-066036 · doc4.xml · nonDerivative · entry 1 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,022 Read SEC document |
| September 30, 2021 Filed Sep 30, 2021 16:37 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 50,000 | $1.30 | $64,900.00 |
DisclosureSEC source: 0001209191-21-058141 · doc4.xml · nonDerivative · entry 3 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,101,142 F3 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.27 to $1.32. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| September 29, 2021 Filed Sep 30, 2021 16:37 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 47,500 | $1.28 | $60,657.50 |
DisclosureSEC source: 0001209191-21-058141 · doc4.xml · nonDerivative · entry 2 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,051,142 F2 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.26 to $1.29. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| September 28, 2021 Filed Sep 30, 2021 16:37 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 39,552 | $1.29 | $50,824.32 |
DisclosureSEC source: 0001209191-21-058141 · doc4.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,003,642 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.27 to $1.29. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| August 18, 2021 Filed Aug 18, 2021 20:03 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 11,900 | $1.19 | $14,165.76 |
DisclosureSEC source: 0001209191-21-052200 · doc4.xml · nonDerivative · entry 2 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,022 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.175 to $1.205. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 00:14 UTC |
Elam Nevan CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,288 | $0.00 Strike: $0.52 | $0.00 |
DisclosureSEC source: 0001209191-21-052655 · doc4.xml · derivative · entry 2 Elam Nevan C · CIK 0001314773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,288 shares Expires 2021-08-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option vested and became exercisable in twelve equal quarterly installments beginning on November 18, 2011. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 00:14 UTC |
Elam Nevan CDirector
|
Exercise / conversionCommon Stock | 2,288 | $0.52 | $1,189.76 |
DisclosureSEC source: 0001209191-21-052655 · doc4.xml · nonDerivative · entry 1 Elam Nevan C · CIK 0001314773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 00:12 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 17,788 | $1.22 | $21,701.36 |
DisclosureSEC source: 0001209191-21-052653 · doc4.xml · nonDerivative · entry 3 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 964,090 Read SEC document |
| August 18, 2021 Filed Aug 20, 2021 00:12 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 12,948 | $1.18 | $15,278.64 |
DisclosureSEC source: 0001209191-21-052653 · doc4.xml · nonDerivative · entry 2 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 946,302 Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 20:03 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 15,000 | $1.18 | $17,700.00 |
DisclosureSEC source: 0001209191-21-052200 · doc4.xml · nonDerivative · entry 1 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,122 Read SEC document |
| August 17, 2021 Filed Aug 20, 2021 00:12 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 66,554 | $1.18 | $78,200.95 |
DisclosureSEC source: 0001209191-21-052653 · doc4.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,354 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.17 to $1.18. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| May 21, 2021 Filed May 24, 2021 12:10 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 10,000 | $1.63 | $16,298.00 |
DisclosureSEC source: 0001209191-21-035163 · doc4.xml · nonDerivative · entry 1 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,122 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.625 to $1.63. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| May 19, 2021 Filed May 20, 2021 21:44 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 5,003 | $1.58 | $7,904.74 |
DisclosureSEC source: 0001209191-21-034536 · doc4.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 866,800 Read SEC document |
| May 18, 2021 Filed May 18, 2021 21:36 UTC |
RAMSAY DAVID ADirector
|
PurchaseCommon Stock | 50,000 | $1.62 | $81,100.00 |
DisclosureSEC source: 0001209191-21-033629 · doc4.xml · nonDerivative · entry 1 RAMSAY DAVID A · CIK 0001283292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 861,797 F1 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.58 to $1.67. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| May 17, 2021 Filed May 18, 2021 01:57 UTC |
Chowdhury Badrul A.CHIEF MEDICAL OFFICER
|
SaleCommon Stock | 50,000 | $1.56 | $77,870.00 |
DisclosureSEC source: 0001209191-21-033362 · doc4.xml · nonDerivative · entry 2 Chowdhury Badrul A. · CIK 0001776662 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2020 in order to satisfy tax withholding obligations in connection with the vesting of restricted stock units on May 15, 2021. F2 · price: The price is a weighted average sale price. The sale prices ranged from $1.50 to $1.61. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 15, 2021 Filed May 18, 2021 01:57 UTC |
Chowdhury Badrul A.CHIEF MEDICAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 200,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033362 · doc4.xml · derivative · entry 3 Chowdhury Badrul A. · CIK 0001776662 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units vested in full on May 15, 2021. F3 · derivative.expiration_date: The restricted stock units vested in full on May 15, 2021. Read SEC document |
| May 15, 2021 Filed May 18, 2021 01:57 UTC |
Chowdhury Badrul A.CHIEF MEDICAL OFFICER
|
Exercise / conversionCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033362 · doc4.xml · nonDerivative · entry 1 Chowdhury Badrul A. · CIK 0001776662 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 19, 2021 Filed Apr 19, 2021 18:46 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 27,400 | $1.82 | $49,870.74 |
DisclosureSEC source: 0001209191-21-027226 · doc4.xml · nonDerivative · entry 1 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,122 F1 · shares: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020. F2 · price: The price is a weighted average purchase price. The purchase prices ranged from $1.79 to $1.88. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| March 22, 2021 Filed Mar 23, 2021 01:47 UTC |
Pauls MatthewDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 24,100 | $2.07 | $49,937.61 |
DisclosureSEC source: 0001209191-21-022485 · doc4.xml · nonDerivative · entry 1 Pauls Matthew · CIK 0001573429 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,722 F1 · shares: The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020. F2 · price: The price is a weighted average purchase price. The purchase prices ranged from $2.04 to $2.11. The reporting person undertakes to provide Savara Inc., any security holder of Savara Inc., or the staff of the Securities and Exchange Commission, upon receipt of a request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Read SEC document |
| March 15, 2021 Filed Mar 15, 2021 18:47 UTC |
Lowrance David LCHIEF FINANCIAL OFFICER
|
PurchaseCommon Stock | 13,793 | $1.45 | $19,999.85 |
DisclosureSEC source: 0001209191-21-020416 · doc4.xml · nonDerivative · entry 1 Lowrance David L · CIK 0001408498 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,793 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.